Application no. and date | 12170362.3 (espacenet) (Federated) (European Patent Register), 20120531 | Patent/reg. no. and date | DK/EP 2529756, 20210519 | Publication date | 20121205 | Priority no. and date | WO PCT/EP2011/059001, 20110531, WO PCT/EP2011/059000, 20110531 | EP pub. no. and date |
EP 2529756 20121205 | Effective date | | Applicant/owner | LABORATORIOS FARMACEUTICOS ROVI, S.A., c/Julián Camarillo, 35 28037 Madrid, ES | Applicant ref. no. | LUPV1437681/EP-DK-PGI | Inventor | Gutierro Aduriz, Ibon, C/ Julián Camarillo, 35
28037 Madrid, ES, Franco Rodriguez, Guillermo, C/ Julián Camarillo, 35
28037 Madrid, ES | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61K 47/34 (2017.01) | Title | Risperidon- og/eller paliperidon-implantatformulering | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|